Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.5 USD | -8.03% | -24.14% | 0.00% |
04-22 | Guggenheim Starts Coverage on Boundless Bio With Buy Rating, $24 Price Target | MT |
04-22 | Piper Sandler Starts Audentes Therapeutics With Overweight Rating, $20 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 122M | |
+15.85% | 122B | |
+18.91% | 113B | |
+4.43% | 22.84B | |
-18.63% | 20.72B | |
-13.76% | 16.39B | |
-16.61% | 16.51B | |
-43.53% | 15.83B | |
+1.75% | 13.49B | |
+28.07% | 11.67B |
- Stock Market
- Equities
- BOLD Stock
- News Boundless Bio, Inc.
- Guggenheim Starts Coverage on Boundless Bio With Buy Rating, $24 Price Target